BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17069736)

  • 1. [Prevention of peritonitis in patients with peritoneal dialysis].
    Ivarsen PR; Møller JK; Povlsen JV
    Ugeskr Laeger; 2006 Oct; 168(43):3714-7. PubMed ID: 17069736
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
    Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
    Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis.
    Xu G; Tu W; Xu C
    Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of methods to prevent peritoneal dialysis catheter infections.
    Piraino B; Bernardini J; Bender FH
    Perit Dial Int; 2008; 28(5):437-43. PubMed ID: 18708532
    [No Abstract]   [Full Text] [Related]  

  • 7. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S86-90. PubMed ID: 15469567
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic prophylaxis before peritoneal dialysis catheter insertion.
    Katyal A; Mahale A; Khanna R
    Adv Perit Dial; 2002; 18():112-5. PubMed ID: 12402600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylactic antibiotics for insertion of peritoneal dialysis catheter.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S72-5. PubMed ID: 15469562
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 11. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective?
    Piraino B
    Nephrol Dial Transplant; 2010 Feb; 25(2):349-52. PubMed ID: 19934078
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversies in the management of infective complications of peritoneal dialysis.
    Odudu A; Wilkie M
    Nephron Clin Pract; 2011; 118(3):c301-8. PubMed ID: 21242698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis in chronic peritoneal dialysis patients.
    Gauntner WC; Feldman HA; Puschett JB
    Clin Nephrol; 1980 Jun; 13(6):255-9. PubMed ID: 7408243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
    Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
    Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis.
    Wong C; Luk IW; Ip M; You JH
    Am J Infect Control; 2014 Apr; 42(4):412-6. PubMed ID: 24679568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
    Morey A; Lima C; Matas B; Munar MA
    Nefrologia; 2001; 21(6):608. PubMed ID: 11881434
    [No Abstract]   [Full Text] [Related]  

  • 19. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: treatment of peritoneal dialysis-associated fungal peritonitis.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S78-81. PubMed ID: 15469564
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.